This author has no more entries published after this entry.

United States Clinical Oncology Next Generation Sequencing Market: Key Drivers and Disruptive Trends Shaping the Future [2029] in Automotive Pressure Sensors Market Size 2027: Projected Growth and Opportunities | Techsci Research

Revised: 10/18/2024 9:27 a.m.

  • Sept. 4, 2024, midnight
  • |
  • Public

Introduction
The clinical oncology landscape in the United States is undergoing a significant transformation, propelled by advancements in genomics and molecular biology. These developments have led to the emergence of innovative technologies, such as Next Generation Sequencing (NGS), which is revolutionizing cancer diagnosis and treatment. According to TechSci Research, the United States Clinical Oncology Next Generation Sequencing Market was valued at USD 159.21 million in 2022 and is projected to grow at a CAGR of 9.12% from 2024 to 2028. This report delves into the key dynamics, emerging trends, and competitive landscape shaping this market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “United States Clinical Oncology Next Generation Sequencing Market.” - https://www.techsciresearch.com/report/united-states-clinical-oncology-next-generation-sequencing-market/20618.html


Last updated October 18, 2024


Loading comments...

You must be logged in to comment. Please sign in or join Prosebox to leave a comment.